Wide complex tachycardia resident survival guide
Wide Complex Tachycardia Resident Survival Guide Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
For the mobile version, click here
Overview
Wide complex tachycardia is characterized by a heart rate more than 100 beats per minute associated with a QRS interval of more than 120 ms. When wide complex tachycardia is present, it is important to determine whether the tachycardia is of a supraventricular or a ventricular origin. The diagnosis of wide complex tachycardia is very challenging as there is no fixed criteria to accurately determine the cause and type of the WCT. Hemodynamically unstable patients should receive urgent synchronized cardioversion. If the QRS complex and the T wave can't be distinguished in unstable patients, then we proceed with unsynchronized cardioversion.[1]
Causes
Life Threatening Causes
Wide complex tachycardia may be a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
- Atrial fibrillation with aberrancy
- Atrial fibrillation with pre-excitation
- Supraventricular tachycardia (SVT) with aberrancy
- Ventricular tachycardia
Click here for the complete list of causes.
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) as shown below should be performed to identify patients in need of immediate intervention.[1][2]
Boxes in salmon signify that an urgent management is needed.
Identify cardinal findings that increase the pretest probability of wide complex tachycardia ❑ Palpitations ❑ QRS complex > 120 ms ❑ Heart rate > 150 beats/min | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Does the patient have any of the following findings that require urgent cardioversion? ❑ Hemodynamic instability ❑ Chest discomfort suggestive of ischemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Yes | ❑ No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepare the patient for immediate cardioversion and simultaneously do the following: ❑ Maintain patent airway; assist breathing as necessary ❑ Adminster oxygen (if the patient is hypoxemic) ❑ Cardiac monitor to identify rhythm; monitor blood pressure and oximetry ❑ Give IV sedation if the patient is conscious ❑ Don't delay cardioversion to sedate the patient ❑ Consider expert consultation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unsynchronized cardioversion ❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks
| Synchronized cardioversion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atrial fibrillation with aberrancy
| Arial flutter and other SVTs with aberrancy
| Monomorphic VT (regular form and rate)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If you can't determine the type of arrhythmia or you aren't sure, go for immediate unsynchronized cardioversion
Complete Diagnostic Approach
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]
Abbreviations: ECG: Electrocardiogram; VT: Ventricular tachycardia; VF: Ventricular fibrillation; ICD: Implantable cardioverter-defibrillator; BPM: Beat per minute; AT: Atrial tachycardia; RBBB: Right bundle branch block; LBBB: Left bundle branch block; SVT: supraventricular tachycardia; AP: Accessory pathway; AVRT: Atrioventricular reentrant tachycardia; SR: Sinus rhythm; A: Atrial; V: Ventricular
Characterize the symptoms: ❑ Palpitations
❑ Duration
| |||||||||||||||||||||||||||||||||||||||||||||||||
Identify possible triggers: | |||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient:
Neck
Cardiovascular examination
❑ Palpation
❑ Auscultation
| |||||||||||||||||||||||||||||||||||||||||||||||||
Order labs and tests: ❑ Order and monitor the ECG Perform urgent cardioversion in unstable patients
❑ Invasive electrophysiological studies ❑ Plasma concentration of drugs (eg, digoxin, quinidine or procainamide) | |||||||||||||||||||||||||||||||||||||||||||||||||
Wide QRS complex tachycardia (QRS duration greater than 120 ms) | |||||||||||||||||||||||||||||||||||||||||||||||||
Regular or irregular? | |||||||||||||||||||||||||||||||||||||||||||||||||
Regular | Irregular | ||||||||||||||||||||||||||||||||||||||||||||||||
Is QRS identical to that during SR? If yes, consider: - SVT and BBB - Antidromic AVRT | Atrial fibrillation Atrial flutter / AT with variable conduction and: a) BBB or b) Antegrade conduction via AP | ||||||||||||||||||||||||||||||||||||||||||||||||
Vagal maneuvers or adenosine | |||||||||||||||||||||||||||||||||||||||||||||||||
Previous myocardial infarction or structural heart disease? If yes, VT is likely. | |||||||||||||||||||||||||||||||||||||||||||||||||
1 to 1 AV relationship? | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes or unknown | No | ||||||||||||||||||||||||||||||||||||||||||||||||
V rate faster than A rate | A rate faster than V rate | ||||||||||||||||||||||||||||||||||||||||||||||||
QRS morphology in precordial leads | VT | Atrial tachycardia Atrial flutter | |||||||||||||||||||||||||||||||||||||||||||||||
Typical RBBB or LBBB | Precordial leads: - Concordant - No R/S pattern - Onset of R to nadir longer than 100ms | RBBB pattern: - qR, Rs or Rr' in V1 - Frontal plane axis range from +90 degrees to -90 degrees | LBBB pattern: - R in V1 longer than 30 ms - R to nadir of S in V1 greater than 60 ms - qR or qS in V6 | ||||||||||||||||||||||||||||||||||||||||||||||
SVT | VT | VT | VT | ||||||||||||||||||||||||||||||||||||||||||||||
The above algorithm is adapted from the 2003 American College of Cardiology.[1]
Click here for more details about classification of wide complex tachycardia.
Treatment
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]
CAB: Circulation, airway and breathing; Afib: Atrial fibrillation; BBB: Bundle branch block; LV: Left ventricle; SVT: Supraventricular tachycardia; VT: Ventricular tachycardia; WPW: Wolff Parkinson White
Wide complex tachycardia QRS ≥ 120ms | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Begin initial management ❑ Assess and support CAB as needed ❑ Give oxygen | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Determine if the patient has any unstable sign or symptom ❑ Chest pain ❑ Congestive heart failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Determine the regularity of the rhythm | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Irregular rhythm | Regular rhythm | ||||||||||||||||||||||||||||||||||||||||||||||||||||
VT or uncertain rhythm Procainamide (Class IIa, level of evidence B) ❑ Adminster 20-50 mg/min IV untill arrhythmia suppressed, hypotension ensues, QRS duration increase by 50 %, or maximum dose of 17 mg/kg is given ❑ Maintenance infusion: 1-4 mg/min ❑ Avoide procainamide if prolonged QT interval or CHF Amiodarone (Class IIb, level of evidence B) ❑ Give amiodarone 150 mg IV over 10 min ❑ Repeat amiodarone as needed for a maximal dose of 2.2g/24h | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Recurrent polymorphic VT ❑ Consider expert consultation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating SVT from VT
Shown below is a table summarizing some clues that help differentiate SVT from VT.[1]
Clues | Type of arrhythmia |
Irregularly irregular rhythm | Atrial fibrillation or atrial flutter with aberrancy |
Previous myocardial infarction or structural heart disease | Ventricular tachycardia |
Ventricular rate faster than atrial rate | Ventricular tachycardia |
Typical RBBB or LBBB | Supraventricular tachycardia |
Precordial leads: ❑ Concordant ❑ No R/S pattern ❑ Onset of R to nadir longer than 100ms |
Ventricular tachycardia |
RBBB pattern: ❑ qR, Rs or Rr' in V1 ❑ Frontal plane axis range from +90 degrees to -90 degrees |
Ventricular tachycardia |
LBBB pattern: ❑ R in V1 longer than 30 ms ❑ R to nadir of S in V1 greater than 60 ms ❑ qR or qS in V6 |
Ventricular tachycardia |
For more details about differentiating VT from SVT, click here
Antiarrhythmics
Shown below is a table summarizing the choices of the antiarrhythmic drugs for the different types of tachycardia according to the 2003 ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias.[1]
BBB: Bundle branch block; LV: Left ventricle; SVT: Supraventricular tachycardia
Do's
- Use high energy unsynchronized cardioversion immediately if you aren't sure of the type of arrhythmia.
- Monitor the patient all the time as he might be unstable or pulseless at anytime.
- Consider adenosine as a safe and potentially effective therapy in the initial management of stable undifferentiated regular monomorphic wide complex tachycardia.[2]
- Refer the patient to an arrhythmia specialist when the tachycardia causes syncope or dyspnea as well as when the wide complex tachycardia is of unknown cause.[1]
- Place an ambulatory 24 hour Holter when the tachycardia is frequent and transient.[1]
- Treat the patient as having a ventricular tachycardia when the diagnosis of supraventricular tachycardia can not be made.[1]
- Suspect ventricular tachycardia in a patient with wide complex tachycardia and previous myocardial infarction or a history of structural heart disease.[1]
- Use beta blockers with caution in pulmonary diseases or congestive heart failure.
- Balance the use of IV analgesics or sedatives with the risk of further hemodynamic deterioration.
Dont's
- Don't rely on the hemodynamic status of the patient and the heart rate to differenciate SVT from VT and this might lead to inappropriate dangerous therapy.
- Don't delay cardioversion to sedate or to establish an IV line to the patient.
- Don't adminster verapamil for wide complex tachycardia unless known to be of supraventricular origin.[2]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ; et al. (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". J Am Coll Cardiol. 42 (8): 1493–531. PMID 14563598.
- ↑ 2.0 2.1 2.2 2.3 2.4 "Part 7.3: Management of Symptomatic Bradycardia and Tachycardia". Retrieved 2 March 2014.